Compound Summary
Compound Information
药名: | Uvadex |
别名: | DSSTox_GSID_20830; Methoxsalen plus ultraviolet radiation; 8-Methoxy-4',5',6,7-furocoumarin; NC00652; CC-30277; 9-Methoxy-7H-furo[3,2-g]chromen-7-one #; 9-Methoxyfuro(3,2-g)chromen-7-one; HMS2091D20; 4CN-0934; AK111265; 9-METHOXY-2H-FURO[3,2-G]CHROMEN-2-ONE; 9-methoxyfuro[3,2-g]chromen-7-one; Vitpso; NCGC00060938-02; U4VJ29L7BQ; SPBio_002557; 8-MOP; 8-Methoxy-4',6,7-furocoumarin; SDCCGMLS-0042377.P002; CPD000071170; Spectrum2_001052; s1952; NCGC00060938-03; Delta Brand of Methoxsalen; 9-(methyloxy)-7H-furo[3,2-g]chromen-7-one; Methoxsalen, United States Pharmacopeia (USP) Reference Standard; Oxsoralen lotion; Oxsoralen; Dltasoralen; 8-Methoxy-6,7-furanocoumarin; Methoxsalen Canderm Brand; HMS2269P03; DSSTox_CID_830; NINDS_000763; KBioSS_001503; AB2000388; Methoxaten; EINECS 206-066-9; Meladinina; C01864; Methoxa-Dome; Oxoralen; Psoralen-mop; Xanthotoxin, analytical standard; NCGC00016418-04; CAS-298-81-7; KBio3_001497; AJ-39565; AN-12178; Methoxsalen [BAN:JAN]; NCGC00060938-05; 8-Methoxypsoralen, analytical standard; Dermatech Brand of Methoxsalen; 9-Methoxy-7H-furo[3,2-g][1]benzopyran-7-one; NCGC00060938-04; NCGC00060938-06; CM-131; 8-Methoxyfuranocoumarin; Xanthotoxine; 12692-94-3; Prestwick0_000479; 8-Methoxy-2',6,7-furocoumarin; 5-Demethoxyisoimpinellin; Methoxy-8-psoralen; SMR000071170; SCHEMBL19168; MEGxp0_000095; LS-68; HSDB 2505; CS-1983; SC-13812; 9-methoxyfurano[3,2-g]chromen-2-one; NCGC00016418-03; ZINC2548959; Dermox; Psoralon-MOP; Canderm Brand of Methoxsalen; 8-methoxy-4'',5'':6,7-furocoumarin; 8MOP; Meladinin (VAN); 298M817; Oprea1_166319; NCGC00016418-14; OXSORALEN (TN); Meladinine; Oxsoralen Ultra; 7H-Furo[3, 9-methoxy-; Prestwick1_000479; AC-4259; BG00605120; Tox21_110432; BG0479; HMS3655B05; WLN: T C566 DO LVOJ BO1; Boehringer Ingelheim Brand of Methoxsalen; Uvadex; Puvamet; Sanofi Synthelabo Brand of Methoxsalen; Prestwick3_000479; NSC757114; Meladoxen; NCGC00016418-09; 5-19-06-00015 (Beilstein Handbook Reference); SAM002548974; 8-methoxyfurocoumarins; 8-methoxyfuranocoumarins; SR-01000629727-4; Oxsoralen-ultra; Q039; an 8-methoxyfurocoumarin; 8MO; methoxsalen; MFCD00005009; NCGC00178871-03; BSPBio_000618; Tox21_110432_1; MolPort-000-696-480; NCI-C55903; DSSTox_RID_75816; NCGC00016418-02; AB00052042_16; BRN 0196453; Xanthotoxin;Metoxaleno; Dltasoralen;Meladinine;Uvadex,;Oxsoralen; NCGC00016418-07; Zanthotoxin; BRD-K63430059-001-06-5; BDBM50041234; KBio2_004071; 8-METHOXYPSORALEN + UVA (SEE ALSO C55903); Methoxsalen Mex-America Brand; DB00553; Metoxaleno; 8-methoxy-[furano-3''.2'':6.7-coumarin]; NCGC00016418-10; 9-Methoxy-7H-furo[3,2- g][1]benzopyran-7-one; Spectrum_001023; Methoxa Dome; Methoxsalen (JP17/USP); 8-Methoxypsoralene; Methoxalen; EN300-52504; 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, .delta.-lactone; CHEBI:18358; HMS502G05; GP5578; I06-0695; MLS000062633; Tox21_302816; D08SKH; BC4157549; ICN Brand 1 of Methoxsalen; AB00052042-14; 8-methoxypsoralen; Proralone-mop; X0009; AC1L1HFY; Oxypsoralen; Methoxsalen Sanofi-Synthelabo Brand; FT-0602101; Q-100381; 9-Methoxypsoralen; ST24045871; Methoxsalen with ultra-violet A theraphy; NSC 45923; 8-Methoxy-(furano-3'.2':6.7-coumarin); Prestwick_661; 8-Methoxypsoralen with ultraviolet A therapy; Pharmakon1600-01500400; Sanofi-Synthelabo Brand of Methoxsalen; NCGC00016418-08; QXKHYNVANLEOEG-UHFFFAOYSA-N; FT-0082222; BRD-K63430059-001-03-2; 9-Methoxyfuro[3,2-g][1]benzopyran-7-one; xanthotoxin ; BPBio1_000680; Methoxsalen Delta Brand; Mex-America Brand of Methoxsalen; AX8020056; C-11618; KS-00000J91; STOCK1N-03091; NCGC00256435-01; 9-Methoxy-7H-furo[3,2-g]chromen-7-one; Deltapsoralen; Oxsoralen Ul tra; 6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone; IDI1_000763; D00139; Spectrum4_000052; SR-01000629727-2; Deltasoralen; CCRIS 2083; ICN Brand 3 of Methoxsalen; Meloxine; Prestwick2_000479; JC10026; J10204; 7-Furocoumarin; CHEMBL416; BSPBio_001997; Methoxsalen (JP15/USP); Geroxalen; 8-MOP ; Methoxsalen; KBio2_001503; NSC-757114; NSC45923; Ultramop; Methoxsalen Chinoin Brand; AM84906; 8-Methoxy-4',5':6,7-furocoumarin; Ammodin; Jsp005650; MCULE-2500932325; 8-MP; Methoxsalen [USP:BAN:JAN]; O-methylxanthotoxol; 9-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; KBioGR_000543; DS-5159; UVADEX (TN); Methoxsalen, 8-; Methoxsalene; STK735539; 9-metho xy-7H-furo(3,2-g)benzopyran-7-one; Methoxsalen Dermatech Brand; 8-Methoxy-2',3',6,7-furocoumarin; NCGC00016418-05; NCGC00259316-01; DTXSID8020830; ACon1_000174; DB Brand of Methoxsalen; Tox21_201767; N1305; NCGC00178871-01; Ultra Mop; Puvalen; Methoxsalen (Oxsoralen); DivK1c_000763; Chinoin Brand of Methoxsalen; NSC-45923; Ammoidin; 8-Methoxypsoralen; NCGC00178871-02; SAM002564221; Meladinin; SR-01000629727; SBB005950; 8-Methoxy(furano-3'.2':6.7-coumarin); NCI60_004085; SBI-0051443.P003; SPBio_001004; NCGC00016418-12; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-methoxy-; XANTHOTOXIN; 9-Methoxy-7H-furo(3,2-g)benzopyran-7-one; ICN Brand 2 of Methoxsalen; 8-Methoxy; SPECTRUM1500400; 8 Methoxypsoralen; HMS2096O20; HY-30151; 298-81-7; HMS3259L13; Spectrum5_001891; AKOS000277012; 8-methoxy-2'',3'',6,7-furocoumarin; AB00052042_17; 7H-Furo(3,2-G)(1)benzopyran-7-one, 9-methoxy-; UNII-U4VJ29L7BQ; NCGC00016418-11; MLS002303011; Z1258578369; AB00052042-15; Spectrum3_000499; Galderma Brand of Methoxsalen; BC204608; KBio2_006639; NCGC00016418-01; 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, delta-lactone; NCGC00016418-06; HMS1920N05; HMS1569O20; New-Meladinin; API0008254; Mex America Brand of Methoxsalen; 8-Methoxy-[furano-3'.2':6.7-coumarin]; NCGC00016418-15; KBio1_000763; BG01521511; A1783/0075596; CCG-36366; ST041029; Ultramop Lotion;8-methoxypsoralen;Methoxsalen plus ultraviolet radiation; 8-Methoxy-4',5',6,7-furocoumarin; 9-Methoxyfuro(3,2-g)chromen-7-one; Methoxsalen; NCGC00060938-02; 9-methoxyfuro[3,2-g]chromen-7-one; SDCCGMLS-0042377.P002; SPBio_002557; 8-MOP; Spectrum2_001052; NCGC00060938-03; 9-(methyloxy)-7H-furo[3,2-g]chromen-7-one; Oxsoralen; 8-MOP Capsules; NINDS_000763; KBioSS_001503; EINECS 206-066-9; C01864; Methoxa-Dome; Oxoralen; CAS-298-81-7; KBio3_001497; Methoxsalen [BAN:JAN]; NCGC00060938-06; NCGC00060938-04; DRG-0088; 8-Methoxyfuranocoumarin; Prestwick0_000479; 12692-94-3; Xanthotoxine; Methoxy-8-psoralen; SMR000071170; MEGxp0_000095; HSDB 2505; Psoralon-MOP; Meladinin (VAN); Oprea1_166319; Meladinine; Oxsoralen Ultra; Prestwick1_000479; WLN: T C566 DO LVOJ BO1; Prestwick3_000479; Meladoxen; 5-19-06-00015 (Beilstein Handbook Reference); AIDS001590; 8MO; BSPBio_000618; NCI-C55903; BRN 0196453; KBio2_004071; ZINC00381730; Spectrum_001023; 8-Methoxypsoralene; 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, .delta.-lactone; Methoxalen; MLS000062633; Oxypsoralen; 9-Methoxypsoralen; Methoxsalen with ultra-violet A theraphy; NSC 45923; 8-Methoxy-(furano-3'.2':6.7-coumarin); Prestwick_661; 8-Methoxypsoralen with ultraviolet A therapy; 9-methoxy-7H-furo[3,2-g]chromen-7-one; 9-Methoxyfuro[3,2-g][1]benzopyran-7-one; BPBio1_000680; 9-METHOXY-7H-FURO[3,2-G][1]BENZOPYRAN-7-ONE; IDI1_000763; D00139; 6-Hydroxy-7-methoxy-5-benzofuranacrylic acid delta-lactone; Spectrum4_000052; CCRIS 2083; Meloxine; Prestwick2_000479; BSPBio_001997; Methoxsalen (JP15/USP); Geroxalen; KBio2_001503; NSC45923; Ammodin; 8-MP; 9-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; KBioGR_000543; Methoxsalen, 8-; 8-Methoxy-2',3',6,7-furocoumarin; AIDS-001590; ACon1_000174; Puvalen; Oxsoralen (TN); DivK1c_000763; Ammoidin; 8-Methoxypsoralen; Meladinin; NCI60_004085; 8-Methoxy(furano-3'.2':6.7-coumarin); SPBio_001004; Oxsoralen-Ultra; 7H-Furo[3,2-g][1]benzopyran-7-one, 9-methoxy-; SPECTRUM1500400; 298-81-7; Spectrum5_001891; Xanthotoxin; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-methoxy-; Spectrum3_000499; 9-methoxy-7-furo[3,2-g]chromenone; NCGC00016418-01; KBio2_006639; 5-Benzofuranacrylic acid, 6-hydroxy-7-methoxy-, delta-lactone; M3501_SIAL; New-Meladinin; Oxsoralen Lotion; 10-32-2; 8-Methoxy-[furano-3'.2':6.7-coumarin]; A1783/0075596; KBio1_000763; |
分子式: | C12H8O4 |
Smiles: | COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2 |
成分: | HBIN048463;HBIN013820;HBIN047654 |
OB_score: | 35.295554 |
CAS_id: | 298-81-7;12692-94-3 |
SymMap_id: | SMIT01660;SMIT04286 |
TCMID_id: | 22758;29497 |
TCMSP_id: | MOL001953 |
PubChem_id: | 4114 |
DrugBank_id: | DB00553 |
化合物对应的植物
| 植物ID | 拉丁名 | 药用植物名 | 药名 | 来源 | 功能与主治 | 使用民族 |
|---|
| TCMBANKHE000757 | Radix Adenophorae | 南沙参 | To nourish yin and remove heat from the lung, to relieve phlegm, and to reinforce qi./Treament of heat in the lung with dry cough, cough with scanty sticky sputum in phthisis with deficiency of yin , deficiency of both qi and yin with feverishness and thirst. | |||
| TCMBANKHE001687 | 大皂荚 | |||||
| TCMBANKHE002815 | 牛大力 | |||||
| TCMBANKHE003461 | 紫花前胡 | |||||
| TCMBANKHE005444 | 白鲜皮 | To clear heat and dry damp, dispel wind and relieve itch, resolve toxin./1. Inhibiting the growth of pathogenic fungi. 2. Its infusion lowers vaccine-induced fever in rabbits. 3. Dictamnine, one of its active components, increase the myocardial tone of frogs. Dermatitis, psoriasis, icterohepatitis, damp-heat sore and papules, profuse pus, yellow-water sore, damp ulceration on skin, itchy skin, damp-heat jaundice, damp-heat impediment. | ||||
| TCMBANKHE004086 | Plumula Nelumbinis | 莲子心 | To remove heat from the heart and calm the nerves, to restore the coordination between the heart and the kidney, to check emission, and to arrest bleeding./Heat entering pericardium, clouded spirit with delirious speech, non-interaction of heart and kidney, insomnia and emission, blood ejection due to blood heat, hypertension. | |||
| TCMBANKHE004107 | Carassius auratus | 金鱼 | To clear heat, disinhibit water, resolve toxin./Cough, jaundice, ascites ulcer. | |||
| TCMBANKHE004137 | Ammi majus | 大阿米 | ||||
| TCMBANKHE004381 | Heracleum sphondylium | 牛防风 | ||||
| TCMBANKHE004556 | fructus Foeniculi | 小茴香 | 1. To dispel cold and stop pain; 2. To regulate qi and harmonize the stomach/1. An active component, anisaldehyde, in creases the effect of streptomycin on experimental tuberculosis in mice.2. Accelerating gastrointestinal peristalsis, and promoting eliminating of flatus.3. Eliminating phlegm. | |||
| TCMBANKHE007459 | Peucedanum praeruptorum | 白花前胡 | See Angelica decursiva ./See Angelica decursiva. | |||
| TCMBANKHE005027 | 苦楝皮 | Ascariasis, oxyuria disease, abdominal pain due to worm accumulation, scab and lichen with itching. | ||||
| TCMBANKHE005139 | Radix Angelicae Dahuricae | 白芷 | To dispel wind, to remove damp, to clear the stuffed nose, to relieve pain, and to promote the subsidence ofswelling and drainage of pus./Wind-cold common cold, nasal congestion, headache (especially in forehead and superciliary region), toothache, infections, acute mastitis, sores, excessive leukorrhea, stomachache. | |||
| TCMBANKHE007058 | Pastinaca sativa | 欧防风 | ||||
| TCMBANKHE005406 | Angelica gigas | 朝鲜当归 | To extinguish wind and harmonize blood./Pain in joints, wrenching and contusion. | |||
| TCMBANKHE005452 | Pleurospermum rivulorum | 云南羌活 | To dispel wind and eliminate damp, free network vessels and relieve pain./Wind-cold common cold, wind-cold-damp impediment, hypertonicity of sinews and vessels, headache, pain in stomach duct and abdomen. | |||
| TCMBANKHE005529 | Angelica archangelica | 圆当归 | ||||
| TCMBANKHE007592 | fructus Foeniculi | 小茴香 | 1. To dispel cold and stop pain; 2. To regulate qi and harmonize the stomach/1. An active component, anisaldehyde, in creases the effect of streptomycin on experimental tuberculosis in mice.2. Accelerating gastrointestinal peristalsis, and promoting eliminating of flatus.3. Eliminating phlegm. | |||
| TCMBANKHE006184 | Radix Angelicae Pubescentis | 独活 | To relieve rheumatic conditions, and to remove obstruction from the channels and relieve pain./Wind-cold-damp impediment (especially in lower part of body), pain in lumbus and knees, headache, toothache. | |||
| TCMBANKHE006482 | Angelica officinalis | 药用当归 | ||||
| TCMBANKHE008512 | radix Peucedani | 前胡 | To dispel wind and remove heat, and to relieve cough and resolve phlegm ./Cough, externally contracted wind-heat, lung heat phlegm depression, cough and asthma with abundant phlegm, sticky phlegm, retching counterflow and reduced food intake, fullness and oppression in chest and diaphragm. | |||
| TCMBANKHE006236/XU-723 | Psoralea corylifolia | 补骨脂 | 云南省西双版纳勐腊县 | To supplement kidney and invigorate yang , accept qi and calm asthma, warm spleen and check diarrhea./Fracture, osteomalacia, osteoporosis, kidney yang vacuity, cold pain in lumbus and knees, impotence and emission, frequent urination, enuresis, kidney qi insecurity, vacuity asthma, spleen-kidney vacuity, chronic diarrhea, white patch wind, alopecia areata, psoriasis. | ||
| TCMBANKHE002976/XU-723 | Fructus Psoraleae Corylifoliae|Psoralea corylifolia | 破故纸|补骨脂 | 云南省西双版纳勐腊县 | Treatment of impotence, seminal emission, enuresis, frequent urination, aching of the loins and knees with cold sensation, asthma in deficiency syndromes of the kidney, diarrhea occurring before dawn daily. External use for vitiligo and alpecia areata./1. Corylifolinin ( isobavachalcone ) dilates coronary artery significantly. 2. Promoting phagocytosis of macrophage. 3. Exciting the intestinal smooth muscles in vivo or in vitro, and relaxing the uterus of guinea-pigs in vitro. | ||
| TCMBANKHE004757/XU-374 | Fructus Cnidii|Cnidium monnieri | 蛇床子|蛇床 | 贵州省黔南州望谟县 | To warm the kidney and promote virility, to remove damp, to dispel zvind, and to kill parasites./Impotence, scrotal damp itch, vaginal discharge, pudendal itch, trichomoniasis, eczema, infertility due to uterus cold, wind-damp impediment pain, scab and lichen, damp sore. | ||
| TCMBANKHE009020/XU-638 | Angelica taiwaniana|Angelica dahurica | 杭白芷|滇白芷 | 四川省甘孜州甘孜县 | To dispel wind and eliminate damp, free orifices and relieve pain, disperse swelling and expel pus./Common cold with headache, eyebrow bone pain, toothache, nasal congestion, deep-source nasal congestion, enduring diarrhea due to damp, leukorrhea, sores with welling abscess and flat abscess, poisonous snake bites. | ||
| TCMBANKHE006781/YEM-333 | Radix Saposhnikoviae divaricatae|Saposhnikovia divaricata (Turcz.)Schischk. | 防风 | 防风 | 云南民族药物志：第二卷 | To induce diaphoresis, to dispel wind, to alleviate rheumatic conditions, and to relieve spasm./Migraine, headache and generalized pain, common cold, rheumatoid arthritis, externally contracted wind-cold, wind-damp impediment pain, aching pain in joints, abdominal pain and diarrhea, intestinal wind bleeding, tetanus, wind papule itching, sores. | 阿昌族/傣族/德昂族/景颇族/傈僳族 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
化合物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 |
|---|
| TCMBANKGE000029 | GZMB | C11; CCPI; CGL-1; CGL1; CSP-B; CSPB; CTLA1; CTSGL1; HLP; SECT | granzyme B |
| TCMBANKGE000043 | BHLHE40 | BHLHB2; Clast5; DEC1; HLHB2; SHARP-2; SHARP2; STRA13; Stra14 | basic helix-loop-helix family member e40 |
| TCMBANKGE000137 | PLAU | ATF; BDPLT5; QPD; UPA; URK; u-PA | plasminogen activator, urokinase |
| TCMBANKGE000241 | CASP8 | ALPS2B; CAP4; Casp-8; FLICE; MACH; MCH5 | caspase 8 |
| TCMBANKGE000377 | MITF | CMM8; COMMAD; MI; WS2; WS2A; bHLHe32 | melanocyte inducing transcription factor |
| TCMBANKGE000460 | CYP2A7 | CPA7; CPAD; CYP2A; CYPIIA7; P450-IIA4 | cytochrome P450 family 2 subfamily A member 7 |
| TCMBANKGE000466 | CYP2A6 | CPA6; CYP2A; CYP2A3; CYPIIA6; P450C2A; P450PB | cytochrome P450 family 2 subfamily A member 6 |
| TCMBANKGE000478 | CHEK1 | CHK1 | checkpoint kinase 1 |
| TCMBANKGE000766 | ACHE | ACEE; ARACHE; N-ACHE; YT | acetylcholinesterase (Cartwright blood group) |
| TCMBANKGE000881 | PLAT | T-PA; TPA | plasminogen activator, tissue type |
| TCMBANKGE000988 | HGF | DFNB39; F-TCF; HGFB; HPTA; SF | hepatocyte growth factor |
| TCMBANKGE000992 | KLK3 | APS; KLK2A1; PSA; hK3 | kallikrein related peptidase 3 |
| TCMBANKGE001007 | NR1I2 | BXR; ONR1; PAR; PAR1; PAR2; PARq; PRR; PXR; SAR; SXR | nuclear receptor subfamily 1 group I member 2 |
| TCMBANKGE001008 | CYP3A4 | CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1 | cytochrome P450 family 3 subfamily A member 4 |
| TCMBANKGE001013 | BIRC5 | API4; EPR-1 | baculoviral IAP repeat containing 5 |
| TCMBANKGE001131 | CASP9 | APAF-3; APAF3; ICE-LAP6; MCH6; PPP1R56 | caspase 9 |
| TCMBANKGE001132 | BAX | BCL2L4 | BCL2 associated X, apoptosis regulator |
| TCMBANKGE001156 | CASP3 | CPP32; CPP32B; SCA-1 | caspase 3 |
| TCMBANKGE001166 | BCL2 | Bcl-2; PPP1R50 | BCL2 apoptosis regulator |
| TCMBANKGE001177 | TP53 | BCC7; BMFS5; LFS1; P53; TRP53 | tumor protein p53 |
| TCMBANKGE001620 | TMPRSS6 | IRIDA; MT2 | transmembrane serine protease 6 |
| TCMBANKGE001633 | PRSS48 | ESSPL | serine protease 48 |
| TCMBANKGE002055 | KLK5 | KLK-L2; KLKL2; SCTE | kallikrein related peptidase 5 |
| TCMBANKGE002353 | TPSD1 | MCP7-LIKE; MCP7L1; MMCP-7L | tryptase delta 1 |
| TCMBANKGE002441 | TMPRSS7 | - | transmembrane serine protease 7 |
| TCMBANKGE002490 | AZU1 | AZAMP; AZU; CAP37; HBP; HUMAZUR; NAZC; hHBP | azurocidin 1 |
| TCMBANKGE002588 | KLK1 | KLKR; Klk6; hK1 | kallikrein 1 |
| TCMBANKGE002732 | GZMA | CTLA3; HFSP | granzyme A |
| TCMBANKGE003132 | TMPRSS11D | ASP; HAT | transmembrane serine protease 11D |
| TCMBANKGE003215 | PRSS21 | ESP-1; ESP1; TEST1; TESTISIN | serine protease 21 |
| TCMBANKGE003236 | KLK13 | KLK-L4; KLKL4 | kallikrein related peptidase 13 |
| TCMBANKGE003256 | TMPRSS11A | ECRG1; HATL1; HESP | transmembrane serine protease 11A |
| TCMBANKGE003301 | CORIN | ATC2; CRN; Lrp4; PEE5; TMPRSS10 | corin, serine peptidase |
| TCMBANKGE003602 | CES2 | CE-2; CES2A1; PCE-2; iCE | carboxylesterase 2 |
| TCMBANKGE003643 | F7 | SPCA | coagulation factor VII |
| TCMBANKGE003693 | GZMH | CCP-X; CGL-2; CSP-C; CTLA1; CTSGL2 | granzyme H |
| TCMBANKGE003704 | PRSS40A | TISP43 | serine protease 40A (pseudogene) |
| TCMBANKGE003820 | PRSS42P | PRSS42; TESSP2 | serine protease 42, pseudogene |
| TCMBANKGE004219 | CTSG | CATG; CG | cathepsin G |
| TCMBANKGE004241 | F11 | FXI; PTA | coagulation factor XI |
| TCMBANKGE004684 | KLK6 | Bssp; Klk7; PRSS18; PRSS9; SP59; hK6 | kallikrein related peptidase 6 |
| TCMBANKGE005316 | TMPRSS4 | CAPH2; MT-SP2; TMPRSS3 | transmembrane serine protease 4 |
| TCMBANKGE005358 | CTRB1 | CTRB | chymotrypsinogen B1 |
| TCMBANKGE005516 | PRSS58 | PRSS1; TRY1; TRYX3; UNQ2540 | serine protease 58 |
| TCMBANKGE006000 | TMPRSS9 | - | transmembrane serine protease 9 |
| TCMBANKGE006002 | F12 | HAE3; HAEX; HAF | coagulation factor XII |
| TCMBANKGE006077 | KLK2 | KLK2A2; hGK-1; hK2 | kallikrein related peptidase 2 |
| TCMBANKGE006352 | PROC | APC; PC; PROC1; THPH3; THPH4 | protein C, inactivator of coagulation factors Va and VIIIa |
| TCMBANKGE006354 | PRSS8 | CAP1; PROSTASIN | serine protease 8 |
| TCMBANKGE006400 | PLG | - | plasminogen |
| TCMBANKGE006484 | PRSS36 | - | serine protease 36 |
| TCMBANKGE006690 | PRSS12 | BSSP-3; BSSP3; MRT1 | serine protease 12 |
| TCMBANKGE006803 | OVCH1 | OVCH | ovochymase 1 |
| TCMBANKGE006804 | TMPRSS12 | CT151 | transmembrane serine protease 12 |
| TCMBANKGE006808 | CMA1 | CYH; MCT1; chymase | chymase 1 |
| TCMBANKGE006928 | CTRL | CTRL1 | chymotrypsin like |
| TCMBANKGE006961 | F2 | PT; RPRGL2; THPH1 | coagulation factor II, thrombin |
| TCMBANKGE007218 | PRSS53 | POL3S; UNQ308 | serine protease 53 |
| TCMBANKGE007414 | KLKB1 | KLK3; PKK; PKKD; PPK | kallikrein B1 |
| TCMBANKGE007503 | HABP2 | FSAP; HABP; HGFAL; NMTC5; PHBP | hyaluronan binding protein 2 |
| TCMBANKGE007846 | HAL | HIS; HSTD | histidine ammonia-lyase |
| TCMBANKGE007858 | GZMK | TRYP2 | granzyme K |
| TCMBANKGE008068 | PRTN3 | ACPA; AGP7; C-ANCA; CANCA; MBN; MBT; NP-4; NP4; P29; PR-3; PR3 | proteinase 3 |
| TCMBANKGE008270 | MST1 | D3F15S2; DNF15S2; HGFL; MSP; NF15S2 | macrophage stimulating 1 |
| TCMBANKGE008426 | CTRB2 | - | chymotrypsinogen B2 |
| TCMBANKGE008519 | CTRC | CLCR; ELA4 | chymotrypsin C |
| TCMBANKGE008575 | C1RL | C1RL1; C1RLP; C1r-LP; CLSPa | complement C1r subcomponent like |
| TCMBANKGE008637 | PRSS45P | PRSS45; TESPL; TESSP5 | serine protease 45, pseudogene |
| TCMBANKGE008707 | KLK12 | KLK-L5; KLKL5 | kallikrein related peptidase 12 |
| TCMBANKGE008718 | PRSS3 | MTG; PRSS4; T9; TRY3; TRY4 | serine protease 3 |
| TCMBANKGE008884 | PRSS37 | TRYX2 | serine protease 37 |
| TCMBANKGE009010 | HPN | TMPRSS1 | hepsin |
| TCMBANKGE009022 | KLK9 | KLK-L3; KLKL3 | kallikrein related peptidase 9 |
| TCMBANKGE009092 | F9 | F9 p22; FIX; HEMB; P19; PTC; THPH8 | coagulation factor IX |
| TCMBANKGE009097 | TMPRSS13 | MSP; MSPL; MSPS; TMPRSS11 | transmembrane serine protease 13 |
| TCMBANKGE009251 | PRSS50 | CT20; TSP50 | serine protease 50 |
| TCMBANKGE009310 | CELA2A | AOMS4; ELA2A; PE-1 | chymotrypsin like elastase 2A |
| TCMBANKGE009342 | F10 | FX; FXA | coagulation factor X |
| TCMBANKGE009495 | MASP1 | 3MC1; CRARF; CRARF1; MAP1; MASP; MASP3; MAp44; PRSS5; RaRF | mannan binding lectin serine peptidase 1 |
| TCMBANKGE009570 | LPA | AK38; APOA; LP | lipoprotein(a) |
| TCMBANKGE009584 | TMPRSS11F | HATL4 | transmembrane serine protease 11F |
| TCMBANKGE009683 | KLK15 | ACO; HSRNASPH | kallikrein related peptidase 15 |
| TCMBANKGE009778 | KLK11 | PRSS20; TLSP | kallikrein related peptidase 11 |
| TCMBANKGE009806 | PRSS55 | CT153; T-SP1; TSP1; UNQ9391 | serine protease 55 |
| TCMBANKGE009831 | PRSS54 | CT67; KLKBL4 | serine protease 54 |
| TCMBANKGE009933 | TPSAB1 | TPS1; TPS2; TPSB1; TPSB2; Tryptase-2 | tryptase alpha/beta 1 |
| TCMBANKGE010125 | ACR | - | acrosin |
| TCMBANKGE010277 | CYP2D6 | CPD6; CYP2D; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; P450-DB1; P450C2D; P450DB1 | cytochrome P450 family 2 subfamily D member 6 |
| TCMBANKGE010345 | KLK14 | KLK-L6 | kallikrein related peptidase 14 |
| TCMBANKGE010396 | TMPRSS11E | DESC1; TMPRSS11E2 | transmembrane serine protease 11E |
| TCMBANKGE010469 | C1S | EDSPD2 | complement C1s |
| TCMBANKGE010510 | PRSS27 | CAPH2; MPN | serine protease 27 |
| TCMBANKGE010582 | MASP2 | MAP19; MASP-2; MASP1P1; sMAP | mannan binding lectin serine peptidase 2 |
| TCMBANKGE010708 | PRSS33 | EOS | serine protease 33 |
| TCMBANKGE011031 | CYP2C9 | CPC9; CYP2C; CYP2C10; CYPIIC9; P450IIC9 | cytochrome P450 family 2 subfamily C member 9 |
| TCMBANKGE011079 | PRSS1 | TRP1; TRY1; TRY4; TRYP1 | serine protease 1 |
| TCMBANKGE011169 | PRSS38 | MPN2 | serine protease 38 |
| TCMBANKGE011287 | CFB | AHUS4; ARMD14; BF; BFD; CFAB; CFBD; FB; FBI12; GBG; H2-Bf; PBF2 | complement factor B |
| TCMBANKGE011859 | CFI | AHUS3; ARMD13; C3BINA; C3b-INA; FI; IF; KAF | complement factor I |
| TCMBANKGE011897 | CELA3B | CBPP; ELA3B | chymotrypsin like elastase 3B |
| TCMBANKGE012118 | TMPRSS2 | PRSS10 | transmembrane serine protease 2 |
| TCMBANKGE012272 | CELA1 | ELA1 | chymotrypsin like elastase 1 |
| TCMBANKGE012558 | TMPRSS11B | HATL5 | transmembrane serine protease 11B |
| TCMBANKGE012618 | PRSS57 | NSP4; PRSSL1; UNQ782 | serine protease 57 |
| TCMBANKGE012788 | PRSS22 | BSSP-4; SP001LA; hBSSP-4 | serine protease 22 |
| TCMBANKGE013170 | ELANE | ELA2; GE; HLE; HNE; NE; PMN-E; SCN1 | elastase, neutrophil expressed |
| TCMBANKGE013184 | HP | BP; HP2ALPHA2; HPA1S | haptoglobin |
| TCMBANKGE013331 | TMPRSS15 | ENTK; PRSS7 | transmembrane serine protease 15 |
| TCMBANKGE013347 | PROZ | PZ | protein Z, vitamin K dependent plasma glycoprotein |
| TCMBANKGE013510 | KLK4 | AI2A1; ARM1; EMSP; EMSP1; KLK-L1; PRSS17; PSTS; kallikrein | kallikrein related peptidase 4 |
| TCMBANKGE013570 | CELA3A | ELA3; ELA3A | chymotrypsin like elastase 3A |
| TCMBANKGE013596 | HPR | A-259H10.2; HP | haptoglobin-related protein |
| TCMBANKGE013732 | PRSS46P | PRSS46; TESSP6 | serine protease 46, pseudogene |
| TCMBANKGE014037 | GZMM | LMET1; MET1 | granzyme M |
| TCMBANKGE014164 | KLK8 | HNP; NP; NRPN; PRSS19; TADG14 | kallikrein related peptidase 8 |
| TCMBANKGE014271 | TMPRSS3 | DFNB10; DFNB8; ECHOS1; TADG12 | transmembrane serine protease 3 |
| TCMBANKGE014504 | ST14 | ARCI11; HAI; MT-SP1; MTSP1; PRSS14; SNC19; TADG15; TMPRSS14 | ST14 transmembrane serine protease matriptase |
| TCMBANKGE014638 | CELA2B | ELA2B | chymotrypsin like elastase 2B |
| TCMBANKGE014773 | TMPRSS5 | SPINESIN | transmembrane serine protease 5 |
| TCMBANKGE014839 | TPSG1 | PRSS31; TMT; trpA | tryptase gamma 1 |
| TCMBANKGE014859 | HGFAC | HGFA | HGF activator |
| TCMBANKGE014925 | C2 | ARMD14; CO2 | complement C2 |
| TCMBANKGE014974 | KLK7 | PRSS6; SCCE; hK7 | kallikrein related peptidase 7 |
| TCMBANKGE014999 | CFD | ADIPSIN; ADN; DF; PFD | complement factor D |
| TCMBANKGE015011 | KLK10 | NES1; PRSSL1 | kallikrein related peptidase 10 |
| TCMBANKGE015090 | CYP1A2 | CP12; CYPIA2; P3-450; P450(PA) | cytochrome P450 family 1 subfamily A member 2 |
滇ICP备16009434号-1 |
Dai SX Lab